Verdad Advisers, LP
Reported holdings as of Q2 2026, from 19 quarterly filings.
This filer last reported in Q2 2026; the most recent quarter on file across all filers is Q3 2026. Firms that restructure stop filing under one CIK and start under another, so a successor entity may hold these positions now under a similar name.
Holdings
Download these holdings as CSV
| Security | Ticker | Value | Shares | Weight | Weight change | Held | Change |
|---|---|---|---|---|---|---|---|
| APPLE INC | AAPL | $2.2M | 7,445 | - | new | NEW | |
| BELITE BIO INC | BLTE | $2.1M | 13,758 | -0.45pp | 2q | HELD | |
| ACADIA PHARMACEUTICALS INC | ACAD | $2.1M | 82,629 | +0.29pp | 2q | +21.0%+$362.8K | |
| COMCAST CORP NEW | CMCSA | $2.1M | 84,569 | +0.65pp | 3q | +103.5%+$1.1M | |
| CHATHAM LODGING TR | CLDT | $1.9M | 140,000 | +0.53pp | 3q | HELD | |
| TENAX THERAPEUTICS INC | TENX | $1.8M | 123,174 | flat | 2q | +29.2%+$405.1K | |
| SLIDE INS HLDGS INC | SLDE | $1.8M | 91,070 | +1.07pp | 2q | +197.1%+$1.2M | |
| ZYMEWORKS INC | ZYME | $1.7M | 66,688 | -0.66pp | 2q | -19.4%-$418.5K | |
| AMN HEALTHCARE SVCS INC | AMN | $1.7M | 51,906 | +0.58pp | 3q | +3.8%+$61.7K | |
| X4 PHARMACEUTICALS INC | XFOR | $1.6M | 352,093 | - | new | NEW | |
| VERSANT MEDIA GROUP INC | VSNT | $1.6M | 43,503 | +0.71pp | 2q | +129.0%+$882.5K | |
| NETSCOUT SYS INC | NTCT | $1.4M | 33,128 | +0.85pp | 2q | +125.0%+$801.6K | |
| WHITEHAWK THERAPEUTICS INC | WHWK | $1.4M | 301,483 | +0.87pp | 2q | +161.1%+$851.9K | |
| JOHNSON & JOHNSON | JNJ | $1.4M | 5,384 | -0.18pp | 6q | -0.6%-$8.6K | |
| CONTINEUM THERAPEUTICS INC | CTNM | $1.3M | 81,014 | +0.01pp | 2q | -5.8%-$82.2K | |
| JADE BIOSCIENCES INC | JBIO | $1.3M | 56,384 | - | new | NEW | |
| CISCO SYS INC | CSCO | $1.2M | 10,307 | - | new | NEW | |
| NURIX THERAPEUTICS INC | NRIX | $1.2M | 49,511 | -0.31pp | 2q | -40.7%-$822.8K | |
| PROTARA THERAPEUTICS INC | TARA | $1.2M | 312,249 | - | new | NEW | |
| BLOOMIN BRANDS INC | BLMN | $1.2M | 130,000 | +0.53pp | 3q | +30.0%+$274.2K | |
| TYRA BIOSCIENCES INC | TYRA | $1.1M | 36,003 | - | new | NEW | |
| PAR PAC HOLDINGS INC | PARR | $1.1M | 20,000 | -0.51pp | 2q | -11.1%-$140.2K | |
| EDGEWISE THERAPEUTICS INC | EWTX | $1.1M | 27,234 | +0.60pp | 2q | +108.7%+$576.2K | |
| ALPHABET INC | GOOGL | $1.0M | 2,900 | - | new | NEW | |
| CARTERS INC | CRI | $1.0M | 25,000 | -0.02pp | 3q | HELD | |
| VERA THERAPEUTICS INC | VERA | $1.0M | 23,487 | +0.50pp | 2q | +130.7%+$571.0K | |
| NUVALENT INC | NUVL | $1.0M | 8,104 | - | new | NEW | |
| DIANTHUS THERAPEUTICS INC | DNTH | $980.8K | 10,062 | +0.12pp | 2q | +15.7%+$132.9K | |
| ACLARIS THERAPEUTICS INC | ACRS | $927.2K | 175,272 | +0.06pp | 2q | -11.0%-$115.2K | |
| OPPENHEIMER HLDGS INC | OPY | $915.3K | 8,673 | +0.53pp | 2q | +153.5%+$554.3K | |
| VERIZON COMMUNICATIONS INC | VZ | $886.5K | 20,938 | - | new | NEW | |
| MYERS INDS INC | MYE | $865.1K | 24,500 | - | new | NEW | |
| ENLIVEN THERAPEUTICS INC | ELVN | $860.6K | 16,957 | - | new | NEW | |
| UNIVERSAL INS HLDGS INC | UVE | $850.3K | 20,558 | - | new | NEW | |
| BANK OF NY MELLON CORP | BNY | $831.2K | 5,748 | -0.40pp | 3q | -35.8%-$463.2K | |
| PC CONNECTION INC | CNXN | $809.0K | 11,084 | - | new | NEW | |
| AMERICAN INTEGRITY INS GROUP | AII | $794.2K | 42,178 | -0.13pp | 3q | +2.6%+$20.4K | |
| APPLIED MATLS INC | AMAT | $787.3K | 1,089 | -0.36pp | 2q | -62.4%-$1.3M | |
| ADAPTHEALTH CORP | AHCO | $781.5K | 75,000 | -0.52pp | 2q | -21.1%-$208.4K | |
| ALLSTATE CORP | ALL | $780.2K | 3,279 | - | new | NEW | |
| CELLDEX THERAPEUTICS INC NEW | CLDX | $770.4K | 20,704 | - | new | NEW | |
| REVOLUTION MEDICINES INC | RVMD | $759.0K | 4,053 | -1.63pp | 2q | -81.2%-$3.3M | |
| HERITAGE INSURANCE HLDGS INC | HRTG | $745.2K | 28,575 | -0.07pp | 5q | +7.9%+$54.3K | |
| TD SYNNEX CORPORATION | SNX | $743.2K | 2,780 | +0.44pp | 2q | +92.3%+$356.6K | |
| MOVADO GROUP INC | MOV | $737.5K | 18,762 | +0.41pp | 2q | +74.6%+$315.2K | |
| SMART SAND INC | SND | $714.8K | 142,684 | -0.02pp | 6q | +16.3%+$100.1K | |
| VIRIDIAN THERAPEUTICS INC | VRDN | $711.3K | 38,722 | -0.01pp | 2q | +24.2%+$138.6K | |
| DESIGN THERAPEUTICS INC | DSGN | $688.1K | 47,557 | -0.45pp | 2q | -48.5%-$647.6K | |
| MARCUS & MILLICHAP INC | MMI | $684.9K | 21,972 | +0.19pp | 2q | +41.4%+$200.5K | |
| MATIV HOLDINGS INC | MATV | $681.3K | 90,000 | - | new | NEW | |
| STONEX GROUP INC | SNEX | $673.3K | 5,682 | +0.01pp | 2q | -18.2%-$149.9K | |
| CYTOMX THERAPEUTICS INC | CTMX | $661.5K | 176,407 | +0.47pp | 2q | +484.4%+$548.3K | |
| NET LEASE OFFICE PROPERTIES | NLOP | $654.3K | 58,791 | +0.32pp | 2q | +145.7%+$388.0K | |
| GERON CORP | GERN | $632.6K | 494,201 | - | new | NEW | |
| OOMA INC | OOMA | $630.6K | 32,810 | +0.29pp | 2q | +69.8%+$259.2K | |
| ROCKY BRANDS INC | RCKY | $629.1K | 15,254 | -0.05pp | 3q | +1.7%+$10.5K | |
| JANUX THERAPEUTICS INC | JANX | $620.3K | 40,386 | - | new | NEW | |
| ZOOM COMMUNICATIONS INC | ZM | $615.0K | 7,125 | -1.36pp | 4q | -67.0%-$1.2M | |
| STRUCTURE THERAPEUTICS INC | GPCR | $608.3K | 11,335 | -0.03pp | 2q | HELD | |
| AVALO THERAPEUTICS INC | AVTX | $606.6K | 32,827 | - | new | NEW | |
| MISTRAS GROUP INC | MG | $603.2K | 34,526 | flat | 9q | HELD | |
| VIEMED HEALTHCARE INC | VMD | $602.8K | 52,879 | - | new | NEW | |
| RELMADA THERAPEUTICS INC | RLMD | $602.0K | 86,994 | +0.21pp | 2q | +84.5%+$275.7K | |
| CLIMB BIO INC | CLYM | $601.3K | 46,115 | -0.54pp | 2q | -68.1%-$1.3M | |
| CORBUS PHARMACEUTICALS HLDGS | CRBP | $596.6K | 63,603 | +0.04pp | 2q | +26.6%+$125.2K | |
| BRISTOL-MYERS SQUIBB CO | BMY | $591.4K | 10,263 | - | new | NEW | |
| SECURITY NATL FINL CORP | SNFCA | $581.4K | 60,000 | -0.08pp | 7q | HELD | |
| USANA HEALTH SCIENCES INC | USNA | $556.6K | 26,068 | +0.20pp | 2q | +52.7%+$192.0K | |
| TALKSPACE INC | TALK | $547.3K | 105,252 | -0.50pp | 2q | -40.0%-$365.6K | |
| NVIDIA CORPORATION | NVDA | $547.2K | 2,735 | - | new | NEW | |
| UROGEN PHARMA LTD | URGN | $531.4K | 14,440 | - | new | NEW | |
| ATAIBECKLEY INC | ATAI | $530.6K | 100,681 | -0.40pp | 2q | -55.8%-$669.2K | |
| CALIFORNIA RES CORP | CRC | $528.7K | 10,000 | -1.25pp | 3q | -55.6%-$660.9K | |
| CULLINAN THERAPEUTICS INC | CGEM | $527.9K | 28,987 | +0.30pp | 2q | +130.0%+$298.3K | |
| IBIO INC | IBIO | $523.1K | 298,927 | +0.38pp | 2q | +430.8%+$424.6K | |
| VIATRIS INC | VTRS | $516.1K | 32,500 | flat | 8q | HELD | |
| INNOVAGE HLDG CORP | INNV | $499.3K | 42,139 | +0.19pp | 2q | +33.2%+$124.4K | |
| HELLO GROUP INC | MOMO | $491.2K | 84,685 | -0.50pp | 3q | -43.3%-$374.5K | |
| PMV PHARMACEUTICALS INC | PMVP | $485.6K | 362,361 | +0.21pp | 2q | +101.1%+$244.1K | |
| NATIONAL HEALTHCARE CORP | NHC | $485.1K | 2,295 | - | new | NEW | |
| CIRRUS LOGIC INC | CRUS | $484.9K | 3,265 | -0.06pp | 2q | +0.9%+$4.2K | |
| MICRON TECHNOLOGY INC | MU | $483.6K | 419 | -1.00pp | 3q | -89.1%-$3.9M | |
| JONES LANG LASALLE INC | JLL | $481.0K | 1,552 | -0.62pp | 6q | -50.9%-$499.3K | |
| APA CORPORATION | APA | $474.3K | 14,562 | - | new | NEW | |
| RMR GROUP INC | RMR | $461.8K | 22,496 | - | new | NEW | |
| FULCRUM THERAPEUTICS INC | FULC | $458.3K | 125,224 | - | new | NEW | |
| PROG HOLDINGS INC | PRG | $437.3K | 9,382 | -0.30pp | 2q | -57.9%-$602.1K | |
| SEPTERNA INC | SEPN | $434.4K | 12,970 | - | new | NEW | |
| BIOAGE LABS INC | BIOA | $426.3K | 17,394 | +0.11pp | 2q | +14.4%+$53.5K | |
| TERADYNE INC | TER | $424.8K | 878 | -0.27pp | 3q | -56.4%-$550.6K | |
| ARROW ELECTRS INC | ARW | $421.7K | 1,976 | +0.03pp | 2q | -14.8%-$73.4K | |
| INGLES MKTS INC | IMKTA | $419.3K | 4,734 | - | new | NEW | |
| ERASCA INC | ERAS | $411.5K | 22,460 | -0.21pp | 2q | -32.1%-$194.4K | |
| VIANT TECHNOLOGY INC | DSP | $403.6K | 31,880 | - | new | NEW | |
| QUALCOMM INC | QCOM | $399.3K | 2,161 | - | new | NEW | |
| SHATTUCK LABS INC | STTK | $397.2K | 57,231 | +0.28pp | 2q | +327.8%+$304.3K | |
| ZURA BIO LTD | ZURA | $394.8K | 66,919 | -0.27pp | 2q | -31.1%-$178.1K | |
| LAM RESEARCH CORP | LRCX | $387.0K | 893 | -0.87pp | 3q | -82.7%-$1.9M | |
| SAVARA INC | SVRA | $380.4K | 61,759 | -0.42pp | 2q | -51.9%-$410.4K | |
| MAZE THERAPEUTICS INC | MAZE | $376.5K | 12,618 | - | new | NEW | |
| SANDISK CORP | SNDK | $370.6K | 163 | - | new | NEW | |
| CORNING INC | GLW | $368.3K | 1,442 | - | new | NEW | |
| WESTERN DIGITAL CORP | WDC | $366.0K | 573 | - | new | NEW | |
| NATURES SUNSHINE PRODS INC | NATR | $359.6K | 16,496 | - | new | NEW | |
| KEWAUNEE SCIENTIFIC CORP | KEQU | $355.2K | 10,000 | - | new | NEW | |
| ALUMIS INC | ALMS | $342.9K | 12,187 | +0.10pp | 2q | +32.9%+$84.8K | |
| AMKOR TECHNOLOGY INC | AMKR | $340.5K | 3,949 | - | new | NEW | |
| VTV THERAPEUTICS INC | VTVT | $338.7K | 8,996 | - | new | NEW | |
| VILLAGE SUPER MKT INC | VLGEA | $327.7K | 7,770 | - | new | NEW | |
| KALARIS THERAPEUTICS INC | KLRS | $326.8K | 80,297 | - | new | NEW | |
| CITIGROUP INC | C | $322.0K | 2,301 | - | new | NEW | |
| PLIANT THERAPEUTICS INC | PLRX | $320.7K | 281,343 | +0.17pp | 2q | +186.2%+$208.6K | |
| MERCK & CO INC | MRK | $319.1K | 2,483 | -0.46pp | 6q | -56.1%-$408.2K | |
| HARMONY BIOSCIENCES HLDGS IN | HRMY | $313.3K | 8,604 | - | new | NEW | |
| AMERICAN PUB ED INC | APEI | $312.9K | 5,827 | -0.11pp | 2q | -8.5%-$29.0K | |
| FORMFACTOR INC | FORM | $312.8K | 1,956 | -0.12pp | 2q | -49.5%-$307.2K | |
| NOAH HLDGS LTD | NOAH | $308.9K | 30,922 | -0.05pp | 2q | HELD | |
| AT&T INC | T | $307.4K | 14,852 | - | new | NEW | |
| DOUBLEDOWN INTERACTIVE CO LT | DDI | $306.6K | 26,705 | +0.16pp | 2q | +86.5%+$142.2K | |
| WALMART INC | WMT | $306.3K | 2,704 | - | new | NEW | |
| VISTANCE NETWORKS INC | VISN | $304.2K | 23,806 | - | new | NEW | |
| CLEAR SECURE INC | YOU | $292.4K | 5,246 | - | new | NEW | |
| INTEST CORP | INTT | $280.7K | 15,451 | - | new | NEW | |
| KVH INDS INC | KVHI | $273.4K | 27,592 | - | new | NEW | |
| TERADATA CORP DEL | TDC | $272.1K | 7,852 | - | new | NEW | |
| TACTILE SYS TECHNOLOGY INC | TCMD | $271.4K | 9,115 | +0.03pp | 2q | +16.6%+$38.7K | |
| BREAD FINANCIAL HOLDINGS INC | BFH | $271.2K | 2,503 | - | new | NEW | |
| INGRAM MICRO HLDG CORP | INGM | $260.6K | 9,499 | - | new | NEW | |
| FOGHORN THERAPEUTICS INC | FHTX | $259.8K | 53,231 | +0.12pp | 2q | +118.0%+$140.6K | |
| LINCOLN EDL SVCS CORP | LINC | $259.5K | 5,200 | flat | 2q | -2.5%-$6.7K | |
| FINVOLUTION GROUP | FINV | $257.2K | 53,699 | +0.16pp | 3q | +254.6%+$184.7K | |
| MBX BIOSCIENCES INC | MBX | $252.5K | 4,574 | - | new | NEW | |
| PERDOCEO ED CORP | PRDO | $249.5K | 7,797 | -0.14pp | 3q | -12.9%-$36.9K | |
| BK TECHNOLOGIES CORPORATION | BKTI | $241.9K | 2,814 | flat | 2q | +3.2%+$7.4K | |
| FEDERATED HERMES INC | FHI | $240.5K | 4,355 | -0.64pp | 2q | -68.2%-$516.6K | |
| ANAPTYSBIO INC | ANAB | $236.1K | 3,498 | - | new | NEW | |
| TSCAN THERAPEUTICS INC | TCRX | $228.1K | 232,759 | +0.07pp | 2q | +73.7%+$96.8K | |
| NORTH EUROPEAN OIL RTY TR | NRT | $225.0K | 30,782 | -0.10pp | 3q | HELD | |
| MACYS INC | M | $224.5K | 9,532 | -0.31pp | 3q | -62.8%-$378.5K | |
| JOHNSON OUTDOORS INC | JOUT | $224.2K | 4,869 | - | new | NEW | |
| SILENCE THERAPEUTICS PLC | SLN | $224.0K | 20,400 | - | new | NEW | |
| LB PHARMACEUTICALS INC | LBRX | $222.9K | 6,867 | - | new | NEW | |
| COGENT BIOSCIENCES INC | COGT | $220.8K | 5,705 | -0.02pp | 2q | +7.1%+$14.6K | |
| PHOTRONICS INC | PLAB | $220.4K | 6,775 | - | new | NEW | |
| FIGS INC | FIGS | $219.8K | 21,483 | -0.19pp | 2q | -11.4%-$28.3K | |
| ADICET BIO INC | ACET | $217.7K | 25,200 | - | new | NEW | |
| BICYCLE THERAPEUTICS PLC | BCYC | $216.7K | 51,100 | - | new | NEW | |
| MYRIAD GENETICS INC | MYGN | $214.1K | 37,500 | - | new | NEW | |
| SUTRO BIOPHARMA INC | STRO | $212.5K | 6,400 | - | new | NEW | |
| PALISADE BIO INC | PALI | $208.3K | 99,660 | - | new | NEW | |
| ULTRAGENYX PHARMACEUTICAL IN | RARE | $207.8K | 6,223 | - | new | NEW | |
| FEDEX CORP | FDX | $204.8K | 654 | - | new | NEW | |
| ADEIA INC | ADEA | $203.6K | 6,183 | - | new | NEW | |
| ONESPAN INC | OSPN | $202.5K | 14,112 | - | new | NEW | |
| ENTRADA THERAPEUTICS INC | TRDA | $202.4K | 27,500 | - | new | NEW | |
| IDEAYA BIOSCIENCES INC | IDYA | $201.3K | 5,400 | - | new | NEW | |
| NU SKIN ENTERPRISES INC | NUS | $195.4K | 36,999 | -0.11pp | 3q | +2.3%+$4.4K | |
| ZENTALIS PHARMACEUTICALS INC | ZNTL | $192.1K | 39,608 | - | new | NEW | |
| RISKIFIED LTD | RSKD | $179.6K | 35,637 | +0.09pp | 2q | +96.0%+$88.0K | |
| ALX ONCOLOGY HLDGS INC | ALXO | $170.2K | 82,200 | - | new | NEW | |
| AMARIN CORP PLC | AMRN | $166.3K | 10,431 | - | new | NEW | |
| EGAIN CORP | EGAN | $165.6K | 26,288 | -0.07pp | 3q | HELD | |
| 1STDIBS COM INC | DIBS | $160.0K | 32,661 | -0.08pp | 2q | -13.6%-$25.2K | |
| EASTMAN KODAK CO | KODK | $154.2K | 16,671 | flat | 2q | +12.7%+$17.4K | |
| UPSTREAM BIO INC | UPB | $150.9K | 21,810 | - | new | NEW | |
| INVIVYD INC | IVVD | $150.4K | 172,376 | -0.05pp | 2q | +31.3%+$35.9K | |
| PASSAGE BIO INC | PASG | $150.0K | 30,728 | -0.05pp | 2q | +38.9%+$42.0K | |
| NKARTA INC | NKTX | $145.8K | 51,503 | - | new | NEW | |
| ANNEXON INC | ANNX | $144.5K | 25,300 | -0.19pp | 2q | -52.5%-$159.7K | |
| LEXEO THERAPEUTICS INC | LXEO | $142.4K | 30,591 | - | new | NEW | |
| THE BEACHBODY COMPANY INC | BODI | $142.3K | 13,921 | - | new | NEW | |
| VERRICA PHARMACEUTICALS INC | VRCA | $141.2K | 23,069 | +0.06pp | 2q | +90.7%+$67.1K | |
| PYXIS ONCOLOGY INC | PYXS | $135.1K | 44,899 | - | new | NEW | |
| ONKURE THERAPEUTICS INC | OKUR | $130.7K | 28,660 | - | new | NEW | |
| WEREWOLF THERAPEUTICS INC | HOWL | $125.5K | 348,709 | +0.09pp | 2q | +1071.7%+$114.8K | |
| CALERES INC | CAL | $123.7K | 10,000 | - | new | NEW | |
| CYBIN INC | HELP | $122.3K | 18,500 | - | new | NEW | |
| ALECTOR INC | ALEC | $121.6K | 60,509 | +0.06pp | 2q | +156.9%+$74.3K | |
| VOYAGER THERAPEUTICS INC | VYGR | $120.4K | 34,400 | - | new | NEW | |
| PEPGEN INC | PEPG | $120.4K | 66,880 | +0.01pp | 2q | +23.0%+$22.5K | |
| ACUMEN PHARMACEUTICALS INC | ABOS | $118.8K | 44,478 | +0.01pp | 2q | +19.3%+$19.2K | |
| SPERO THERAPEUTICS INC | SPRO | $113.5K | 51,335 | +0.02pp | 2q | +53.4%+$39.5K | |
| ORGANOGENESIS HLDGS INC | ORGO | $113.2K | 46,600 | - | new | NEW | |
| CENTURY THERAPEUTICS INC | IPSC | $113.2K | 46,200 | - | new | NEW | |
| MEDIFAST INC | MED | $108.6K | 10,234 | -0.05pp | 2q | -22.2%-$30.9K | |
| PRECISION BIOSCIENCES INC | DTIL | $106.3K | 13,527 | - | new | NEW | |
| IMMATICS N.V | IMTX | $106.2K | 10,483 | - | new | NEW | |
| NEXTCURE INC | NXTC | $96.7K | 60,451 | -0.42pp | 2q | +40.7%+$28.0K | |
| OVID THERAPEUTICS INC | OVID | $95.6K | 35,549 | -0.29pp | 2q | -76.6%-$313.0K | |
| VERASTEM INC | VSTM | $92.6K | 24,237 | -0.07pp | 2q | -7.2%-$7.2K | |
| TABOOLA.COM LTD | TBLA | $92.2K | 18,438 | - | new | NEW | |
| LENZ THERAPEUTICS INC | LENZ | $90.3K | 15,900 | - | new | NEW | |
| BGSF INC | BGSF | $82.3K | 14,418 | -0.03pp | 2q | HELD | |
| HYPERLIQUID STRATEGIES INC | PURR | $80.5K | 10,235 | - | new | NEW | |
| Engene Therapeutics Inc | ENGN | $68.0K | 39,300 | - | new | NEW | |
| MACROGENICS INC | MGNX | $66.7K | 14,431 | - | new | NEW | |
| VISTAGEN THERAPEUTICS INC | VTGN | $66.3K | 293,343 | -0.06pp | 2q | +58.6%+$24.5K | |
| GOLD RESOURCE CORP | GORO | $64.6K | 51,232 | +0.04pp | 2q | +248.4%+$46.0K | |
| 8X8 INC NEW | EGHT | $56.8K | 33,208 | +0.03pp | 2q | +170.7%+$35.8K | |
| YIREN DIGITAL LTD | YRD | $51.8K | 61,977 | -0.06pp | 3q | +10.1%+$4.7K | |
| DINGDONG CAYMAN LTD | DDL | $40.9K | 21,170 | -0.02pp | 2q | HELD | |
| AC IMMUNE SA | ACIU | $38.8K | 16,300 | - | new | NEW | |
| PLAYSTUDIOS INC | MYPS | $36.8K | 73,733 | flat | 3q | HELD | |
| PROQR THRAPEUTICS N V | PRQR | $35.5K | 19,100 | - | new | NEW | |
| DRILLING TOOLS INTL CORP | DTI | $29.6K | 15,322 | - | new | NEW | |
| ACRIVON THERAPEUTICS INC | ACRV | $26.8K | 15,054 | - | new | NEW | |
| NAMIB MINERALS | NAMM | $24.0K | 12,748 | - | new | NEW | |
| CONTEXT THERAPEUTICS INC | CNTX | $18.8K | 33,900 | - | new | NEW | |
| KALTURA INC | KLTR | $18.5K | 14,234 | - | new | NEW | |
| VIOMI TECHNOLOGY CO LTD | VIOT | $13.5K | 17,304 | -0.02pp | 3q | -41.7%-$9.7K |
By sector
Industry comes from the SIC code on each company's own SEC filings, which is self-reported and sometimes out of date. Derivative exposure is counted with the shares. Securities the SEC assigns no industry - funds, trusts, foreign issues - are shown as not classified rather than dropped.
| Sector | Value | Share |
|---|---|---|
| Biotech & Pharma | $48.0M | 46.0% |
| Software & IT Services | $6.1M | 5.8% |
| Telecom & Media | $5.3M | 5.1% |
| Insurance | $4.9M | 4.7% |
| Retail & Consumer | $4.8M | 4.6% |
| Business Services | $4.3M | 4.1% |
| Semiconductors & Electronics | $4.1M | 4.0% |
| Computer Hardware | $4.1M | 3.9% |
| Real Estate | $3.7M | 3.5% |
| Healthcare Services | $2.9M | 2.8% |
| Wholesale & Distribution | $2.4M | 2.3% |
| Banks & Lending | $2.4M | 2.3% |
| Other sectors | $10.4M | 9.9% |
| Not classified | $1.0M | 1.0% |
What the disclosed book did
This is not the fund's return. A 13F shows long US equity positions only, so shorts, bonds, foreign listings, private holdings and cash are all invisible here. What this measures is the quarter's change in value of the positions this manager disclosed, had they been left untouched - the return a reader following the filing would have earned.
| Quarter | Book | Market | Difference | Priced |
|---|---|---|---|---|
| Q2 2026 | +19.5% | +14.8% | +4.7% | 97% |
| Q1 2026 | +2.8% | -4.6% | +7.5% | 99% |
| Q4 2024 | -0.4% | +2.1% | -2.5% | 101% |
| Q3 2024 | +7.2% | +5.4% | +1.8% | 100% |
| Q2 2024 | -2.6% | +4.0% | -6.7% | 102% |
| Q1 2024 | +6.4% | +10.0% | -3.6% | 100% |
| Q4 2023 | +14.1% | +11.2% | +2.9% | 100% |
| Q3 2023 | -5.8% | -3.6% | -2.3% | 100% |
Market is SPY over the same two quarter ends, priced the same way as everything else here - the median across every filer reporting it. It is a large-cap US proxy, so a manager holding small caps or biotech will beat or trail it for reasons that are not skill. Prices are quarter-end to quarter-end and say nothing about the path in between, or about trades opened and closed inside a quarter.
Quarter by quarter
| Quarter | Value | Positions | New | Added | Trimmed | Exited | Top 10 | Days to file |
|---|---|---|---|---|---|---|---|---|
| Q2 2026 | $104.4M | 210 | 97 | 59 | 41 | 66 | 18.1% | 45 |
| Q1 2026 | $88.8M | 179 | 133 | 18 | 23 | 58 | 21.2% | 45 |
| Q4 2025 | $87.4M | 104 | 82 | 10 | 11 | 70 | 33.5% | 48 |
| Q3 2024 | $74.9M | 92 | 29 | 21 | 31 | 47 | 32.6% | 45 |
| Q2 2024 | $86.6M | 110 | 16 | 40 | 28 | 53 | 23.6% | 37 |
| Q1 2024 | $91.9M | 147 | 121 | 4 | 18 | 27 | 20.3% | 44 |
| Q4 2023 | $49.3M | 53 | 10 | 6 | 21 | 8 | 49.6% | 40 |
| Q3 2023 | $65.4M | 51 | 15 | 2 | 29 | 10 | 62.0% | 44 |
| Q2 2023 | $63.8M | 46 | 18 | 5 | 13 | 10 | 45.2% | 40 |
| Q1 2023 | $49.7M | 38 | 17 | 7 | 11 | 8 | 42.2% | 42 |
| Q4 2022 | $99.2M | 29 | 9 | 2 | 11 | 5 | 78.1% | 44 |
| Q3 2022 | $68.8M | 25 | 3 | 3 | 10 | 6 | 75.3% | 45 |
| Q2 2022 | $106.1M | 28 | 6 | 5 | 12 | 12 | 76.4% | 46 |
| Q1 2022 | $122.1M | 34 | 7 | 11 | 15 | 15 | 57.2% | 43 |
| Q4 2021 | $147.6M | 42 | 9 | 18 | 14 | 12 | 52.0% | 40 |
| Q3 2021 | $138.4M | 45 | 27 | 5 | 8 | 4 | 51.8% | 43 |
| Q2 2021 | $51.0M | 22 | 4 | 2 | 15 | 19 | 64.8% | 41 |
| Q1 2021 | $313.8M | 37 | 4 | 13 | 10 | 6 | 45.4% | 44 |
| Q4 2020 | $265.5M | 39 | 0 | 0 | 0 | 0 | 45.0% | 47 |
Rows marked UNVERIFIED ID, PLACEHOLDER ID, TICKER AS ID or NON-CUSIP ID carry an identifier that is not a valid CUSIP. They are shown because the filer reported that money, but treat the security named with caution - hover the chip for what is wrong with it, and see the methodology.
Held counts consecutive filings in which this manager reported the position, and can reach further back than the quarters listed above: the tabs begin at Q4 2018 because earlier coverage is too sparse to describe a market, but tenure is counted over every filing we hold, some reaching to 2007. A position sold and later rebought starts again from one.
Weight change is the shift in this position's share of the whole book, in percentage points. It is the more useful column: when money flows into or out of a broad fund, almost every holding is bought or sold at once, so added and trimmed largely track flows. A weight that rose while the book shrank is a decision. Both compare with the previous quarter this filer reported, not the previous calendar quarter.